<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Hagerstown, MD</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40388749</article-id><article-id pub-id-type="pmc">PMC12091646</article-id>
<article-id pub-id-type="publisher-id">MD-D-24-16328</article-id><article-id pub-id-type="art-access-id">00030</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000042505</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version><article-categories><subj-group subj-group-type="heading"><subject>5000</subject></subj-group><subj-group><subject>Research Article</subject><subject>Clinical Case Report</subject></subj-group></article-categories><title-group><article-title>Nocturnal enuresis associated with lithium carbonate extended-release tablets in a girl with major depressive disorder: A case report</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Yanping</given-names></name><degrees>MB</degrees><email>2754932256@qq.com</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Qingqing</given-names></name><degrees>MB</degrees><email>651533793@qq.com</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Dai</surname><given-names>Xianzhen</given-names></name><degrees>MB</degrees><email>1395002489@qq.com</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Pingping</given-names></name><degrees>MM</degrees><email>scmaping@163.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0009-1797-1069</contrib-id><name><surname>Liu</surname><given-names>Bo</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff3" ref-type="aff">c</xref><xref rid="aff4" ref-type="aff">d</xref><xref rid="c1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Tan</surname><given-names>Youguo</given-names></name><degrees>MB</degrees><email>13890055456@163.com</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff4" ref-type="aff">d</xref></contrib><aff id="aff1"><label>a</label> The Zigong Affiliated Hospital, Southwest Medical University, Zigong, China</aff><aff id="aff2"><label>b</label> Department of Auxiliary Examination, Zigong Mental Health Center, Zigong, China</aff><aff id="aff3"><label>c</label> Child and Adolescent Psychosomatic Medicine Center, Zigong Mental Health Center, Zigong, China</aff><aff id="aff4"><label>d</label> Research Center for Psychiatry, Zigong Institute of Brain Science, Zigong, China.</aff></contrib-group><author-notes><corresp id="c1"><label>*</label>Correspondence: Bo Liu, The Zigong Affiliated Hospital, Southwest Medical University, Zigong 643020, China (e-mail: <email xlink:href="liubo2511@163.com">liubo2511@163.com</email>).</corresp></author-notes><pub-date pub-type="collection"><day>16</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>16</day><month>5</month><year>2025</year></pub-date><volume>104</volume><issue>20</issue><elocation-id>e42505</elocation-id><history><date date-type="received"><day>21</day><month>12</month><year>2024</year></date><date date-type="received"><day>25</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>2</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="medi-104-e42505.pdf"/><abstract><sec><title>Rationale:</title><p>Lithium carbonate, a mood stabilizer, is most commonly used for the treatment and prevention of mania and bipolar disorder. Common renal side effects include polyuria and polydipsia. However, when combined with other psychotropic medications that have sedative properties, lithium may increase the risk of nocturnal enuresis.</p></sec><sec><title>Patient concerns:</title><p>A 12-year-old girl experienced recurrent major depressive episodes with psychotic symptoms. Her clinical presentation was complex, including depressed mood, irritability, suicidal ideation or behavior, and partial psychotic features. During treatment, she frequently reported polydipsia, polyuria, and nocturnal enuresis.</p></sec><sec><title>Diagnoses:</title><p>Based on the International Classification of Diseases, 10th Edition, the patient was diagnosed with major depressive disorder with psychotic symptoms (F32.3) and enuresis not due to a physical disorder (F98.0).</p></sec><sec><title>Interventions:</title><p>In addition to receiving antidepressants, antipsychotics, benzodiazepines, and modified electroconvulsive therapy, she was also intermittently treated with lithium carbonate extended-release tablets, with a maximum daily dose of 1.2&#x02009;g. No pathophysiological abnormalities were identified through imaging examinations in relation to her nocturnal enuresis. After suspecting a link between her enuresis and lithium, her nocturnal enuresis resolved following the discontinuation of lithium carbonate extended-release tablets.</p></sec><sec><title>Outcomes:</title><p>During the 4-month follow-up, the patient remained free of nocturnal enuresis, while her depressive and psychotic symptoms significantly subsided.</p></sec><sec><title>Lessons:</title><p>Psychiatrists should be aware of the possibility of lithium-induced nocturnal enuresis when polyuria and polydipsia emerge during lithium treatment, particularly in children and adolescents receiving concomitant psychotropic medications with sedative properties.</p></sec></abstract><kwd-group><kwd>adolescent</kwd><kwd>lithium carbonate extended-release tablet</kwd><kwd>major depressive disorder</kwd><kwd>nocturnal enuresis</kwd><kwd>psychotropics</kwd></kwd-group><funding-group><award-group id="ID0EVSAG141968"><funding-source><institution-wrap><institution>Zigong Science and Technology Program of China</institution><institution-id institution-id-type="doi">10.13039/501100019448</institution-id></institution-wrap></funding-source><award-id>ZG-KY-2023-050</award-id><principal-award-recipient>Youguo Tan</principal-award-recipient></award-group><award-group id="ID0E6UAG141969"><funding-source>the Projects of Zigong Institute of&#x000c2; Brain Science</funding-source><award-id>2023-NKY-01-05</award-id><principal-award-recipient>pingping ma</principal-award-recipient></award-group><award-group id="ID0EAXAG141970"><funding-source>the Projects of Zigong Institute of&#x000c2; Brain Science</funding-source><award-id>2024-NKY-01-04</award-id><principal-award-recipient>bo liu</principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p>Nocturnal enuresis is characterized by intermittent urinary incontinence during sleep in children aged&#x02005;&#x02265;&#x02005;5 years, occurring at least once a month for at least 3 months.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> In the mental health field, medication-related enuresis has been linked to various types of psychotropics, including antidepressants,<sup>[<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>]</sup> antipsychotics,<sup>[<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref>]</sup> antiepileptics,<sup>[<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>]</sup> and benzodiazepines.<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup> For instance, a 55-year-old patient receiving mirtazapine treatment developed enuresis.<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> A small-scale clinical study of 61 Chinese in-patients reported that the incidence of clozapine-induced enuresis was as high as approximately 44%.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> Additionally, a prospective study of 72 children found a secondary enuresis rate of approximately 24% after a mean of 19.8 days of valproate exposure.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup></p><p>Lithium carbonate, as a mood stabilizer, is approved by the Food and Drug Administration as the first-line treatment for bipolar disorder.<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup> It is also effective in reducing the recurrence of depressive episodes and in preventing suicide.<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> Lithium toxicity can occur at doses close to therapeutic levels. The therapeutic range for blood lithium concentration is between 0.6 and 1.2 mmol/L,<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> with toxicity typically observed at levels above 1.4 mmol/L.<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup> The most common toxic effects include gastrointestinal symptoms, such as nausea, vomiting, and diarrhea; neurological symptoms, such as tremors, ataxia, and delirium; and renal symptoms, such as polyuria and polydipsia.<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> Lithium-related enuresis is, however, relatively uncommon compared to other psychotropics. A previous randomized controlled trial involving 60 pediatric patients with bipolar disorder reported that the incidence of lithium-related enuresis was as high as 30%.<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> Another early randomized controlled trial involving 91 children with conduct disorder reported that the incidence of lithium-related enuresis was 17.4%.<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup> Due to improved monitoring of blood lithium concentrations, reports of lithium-related enuresis have become rare in recent years. Furthermore, no reports to date have specifically addressed cases of nocturnal enuresis associated with lithium carbonate extended-release tablets.</p><p>Here, we report a rare case of nocturnal enuresis associated with lithium carbonate extended-release tablets in a girl diagnosed with major depressive disorder. In addition to lithium, she was also treated with antidepressants, antipsychotics, and benzodiazepines. We propose that her nocturnal enuresis may have resulted from an interaction effect between lithium-induced polyuria and the sedative properties of concomitant psychotropic agents.</p></sec><sec sec-type="cases"><title>2. Case presentation</title><p>On November 10, 2023, a 12-year-old girl was admitted to our hospital with a diagnosis of major depressive disorder with psychotic features. She presented with a depressed mood, lack of interest, irritability, and repeated self-injurious behaviors or suicide attempts, including arm cutting, jumping from buildings, jumping into rivers, overdosing on medication, and attempted hanging. Moreover, she also experienced auditory hallucinations, predominantly critical in nature, with some voices issuing imperative commands, such as telling her to die. She believed that those around her intended to harm her and felt the urge to harm others in return. Her laboratory results and detailed treatment regimen are listed in Tables <xref rid="T1" ref-type="table">1</xref> and <xref rid="T2" ref-type="table">2</xref>, respectively. On December 14, 2023, due to her irritable mood and aggressive behaviors, we added lithium carbonate extended-release tablet 0.3&#x02009;g twice daily to her treatment regimen. However, she complained of polydipsia and polyuria during the daytime, along with enuresis every 3 to 5 days at night, as well as lumbar pain. We conducted a urinary ultrasound and spine digital radiography, but no abnormalities were detected (see Fig <xref rid="F1" ref-type="fig">1</xref>). Since the results of her urological workup were negative, we began to suspect the possibility of medication-induced enuresis. We attempted to decrease the dose of clonazepam to 1&#x02009;mg at night, but did not observe significant improvement in her enuresis.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Laboratory results and clinical symptom scores at different timepoints.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Test item</th><th align="center" rowspan="1" colspan="1">November 10, 2023</th><th align="center" rowspan="1" colspan="1">January 5, 2024</th><th align="center" rowspan="1" colspan="1">February 29, 2024</th><th align="center" rowspan="1" colspan="1">August 1, 2024</th><th align="center" rowspan="1" colspan="1">October 3, 2024</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CBC</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td></tr><tr><td align="left" rowspan="1" colspan="1">Liver function</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal function</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td></tr><tr><td align="left" rowspan="1" colspan="1">Thyroidal function</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td></tr><tr><td align="left" rowspan="1" colspan="1">PRL</td><td align="center" rowspan="1" colspan="1">595.6 uIU/mL&#x02191;</td><td align="center" rowspan="1" colspan="1">1574.53 uIU/mL&#x02191;</td><td align="center" rowspan="1" colspan="1">74.99 uIU/mL</td><td align="center" rowspan="1" colspan="1">76.76 uIU/mL</td><td align="center" rowspan="1" colspan="1">112.76 uIU/mL</td></tr><tr><td align="left" rowspan="1" colspan="1">ECG</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Sinus tachycardia</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td></tr><tr><td align="left" rowspan="1" colspan="1">EEG</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Brian MRI</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary ultrasound</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Spine DR</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood lithium</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">0.6 mmol/L</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">1.28 mmol/L</td><td align="center" rowspan="1" colspan="1">0.35 mmol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">SDS</td><td align="center" rowspan="1" colspan="1">89&#x02191;</td><td align="center" rowspan="1" colspan="1">83&#x02191;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">SAS</td><td align="center" rowspan="1" colspan="1">75&#x02191;</td><td align="center" rowspan="1" colspan="1">70&#x02191;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">BPRS</td><td align="center" rowspan="1" colspan="1">47&#x02191;</td><td align="center" rowspan="1" colspan="1">51&#x02191;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>&#x000d7;&#x02005;=&#x02005;no test.</p></fn><fn fn-type="other"><p>EEG = electroencephalogram, BPRS = brief psychiatric rating scale, CBC = complete blood count, DR = digital radiography, ECG = electrocardiogram, MRI = magnetic resonance imaging, PRL = prolactin, SAS = self-rating anxiety scale, SDS = self-rating depression scale.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Timeline of treatment regimens and clinical symptom changes at key time points.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">November 10, 2023</th><th align="center" rowspan="1" colspan="1">December 14, 2023</th><th align="center" rowspan="1" colspan="1">January 5, 2024</th><th align="center" rowspan="1" colspan="1">February 29, 2024</th><th align="center" rowspan="1" colspan="1">April 11, 2024</th><th align="center" rowspan="1" colspan="1">May 9, 2024</th><th align="center" rowspan="1" colspan="1">June 6, 2024</th><th align="center" rowspan="1" colspan="1">August 1, 2024</th><th align="center" rowspan="1" colspan="1">August 26, 2024</th><th align="center" rowspan="1" colspan="1">October 3, 2024</th><th align="center" rowspan="1" colspan="1">December 7, 2024</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sertraline</td><td align="center" rowspan="1" colspan="1">150&#x02009;mg qd</td><td align="center" rowspan="1" colspan="1">150&#x02009;mg qd</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Risperidone</td><td align="center" rowspan="1" colspan="1">2.5&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2.5&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Trazodone</td><td align="center" rowspan="1" colspan="1">100&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">100&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">100&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">100&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Clonazepam</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">1&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">1&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">1.5&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">1.5&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">1&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">0.5&#x02009;mg qn</td></tr><tr><td align="left" rowspan="1" colspan="1">Lithium carbonate ER</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">0.3&#x02009;g bid</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">0.3&#x02009;g bid</td><td align="center" rowspan="1" colspan="1">0.6&#x02009;g bid</td><td align="center" rowspan="1" colspan="1">0.6g bid</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Sodium valproate ER</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">500&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">500&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">1000&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">1000&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Citalopram</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">40&#x02009;mg qd</td><td align="center" rowspan="1" colspan="1">40&#x02009;mg qd</td><td align="center" rowspan="1" colspan="1">40&#x02009;mg qd</td><td align="center" rowspan="1" colspan="1">40&#x02009;mg qd</td><td align="center" rowspan="1" colspan="1">40&#x02009;mg qd</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Aripiprazole</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">20&#x02009;mg qn</td></tr><tr><td align="left" rowspan="1" colspan="1">Benzhexol</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">2&#x02009;mg bid</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Mirtazapine</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">15&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">7.5&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">7.5&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Quetiapine</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg qn</td><td align="center" rowspan="1" colspan="1">100&#x02009;mg qn</td></tr><tr><td align="left" rowspan="1" colspan="1">MECT</td><td align="center" rowspan="1" colspan="1">9 times</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">9 times</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td><td align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" rowspan="1" colspan="1">Enuresis</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02606;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02606;</td><td align="center" rowspan="1" colspan="1">&#x02606;</td><td align="center" rowspan="1" colspan="1">&#x02606;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Depressive mood</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">++</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">++</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">++</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">+</td></tr><tr><td align="left" rowspan="1" colspan="1">Auditory hallucination</td><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Persecutory delusion</td><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Self-injury or suicide</td><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Aggressive behavior</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1">&#x0221a;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>&#x02606; indicates enuresis timepoints;&#x02005;&#x000d7;&#x02005;indicates no use;&#x02005;&#x0221a;&#x02005;indicates the presence of symptom;&#x02005;+&#x02005;indicates mild depression; ++ indicates moderate depression; +++ indicates major depression.</p></fn><fn fn-type="other"><p>ER&#x02005;=&#x02005;extended release, MECT&#x02005;=&#x02005;modified electroconvulsive therapy.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Urological system ultrasonic image and spine bone digital X-ray imaging. No abnormalities were detected. (A) Image of renal structure; (B) image of renal blood stream; (C) bladder image; (D) image of spine bone.</p></caption><graphic xlink:href="medi-104-e42505-g001" position="float"/></fig><p>On January 5, 2024, she experienced a second major depressive episode with psychotic symptoms. She predominantly presented with a severe depressed mood, irritability, and recurrent suicidal behaviors. Given her unstable clinical symptoms and a high blood prolactin level of 1574.53 uIU/mL, we made substantial changes to her treatment regimen, which included Trazodone 100&#x02009;mg/d, Sodium valproate extended release 1000&#x02009;mg/d, Citalopram 40&#x02009;mg/d, and Aripiprazole 20&#x02009;mg/d. Until May 9, 2024, she attended regular follow-up visits, during which her medication dosages were adjusted slightly based on changes in her clinical symptoms. Interestingly, she did not experience any recurrence of nocturnal enuresis during this period. On June 6, 2024, she experienced a moderate depressive episode accompanied by self-injury and aggressive behaviors. Her treatment regimen was readjusted to include clonazepam 1&#x02009;mg/day, lithium carbonate extended-release tablets 0.6&#x02009;g/day, citalopram 40&#x02009;mg/day, aripiprazole 20&#x02009;mg/day, and mirtazapine 15&#x02009;mg/day. Intriguingly, her nocturnal enuresis relapsed, occurring once every 1 to 2 days. After reviewing the specifications of the medications she was taking, examining her medication history, and consulting the literature on medication-related enuresis, we suspected that her nocturnal enuresis might be linked to lithium carbonate, despite the absence of signs of neurotoxicity and a blood lithium concentration of 1.28 mmol/L. As expected, 1 week after discontinuing lithium carbonate on October 3, 2024, her nocturnal enuresis resolved, and her most recent blood lithium concentration was 0.35 mmol/L (see Tables <xref rid="T1" ref-type="table">1</xref> and <xref rid="T2" ref-type="table">2</xref>).</p><p>During a 4-month follow-up period ending on December 7, 2024, she did not experience any recurrence of nocturnal enuresis. Interestingly, her clinical symptoms mostly resolved, and she expressed a desire to return to school. From a retrospective perspective, her history of Lithium carbonate use and the onset of enuresis completely overlapped (see Table <xref rid="T2" ref-type="table">2</xref>), further confirming our hypothesis.</p></sec><sec sec-type="discussion"><title>3. Discussion</title><p>Although we cannot completely rule out the combined effect of lithium carbonate extended-release tablets with other psychotropics on nocturnal enuresis in our case, as these medications have been reported to be associated with enuresis, our thorough review of the case revealed a strong association between the patient&#x02019;s nocturnal enuresis and the use of lithium carbonate extended-release tablets. Her nocturnal enuresis completely overlapped with the medication use and disappeared after it was discontinued. Lithium carbonate extended-release tablets have several advantages compared to conventional lithium carbonate, including more stable blood drug concentrations, fewer adverse events, and less frequent dosing.<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup> To the best of our knowledge, no reports have documented nocturnal enuresis associated with lithium carbonate extended-release tablets.</p><p>The most common urological side effects of lithium include polyuria and polydipsia.<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> Previous studies have reported that lithium can cause nephrogenic diabetes insipidus, which may be linked to reduced kidney sensitivity to vasopressin<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup> and impaired expression of aquaporin-2 in the collecting duct principal cells,<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup> leading to impaired water reabsorption. A case report suggested that lithium may enhance renal prostaglandin activity, leading to polyuria.<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup> In our case, the patient exhibited significant polyuria and polydipsia during the day and enuresis at night. We postulate that her nocturnal enuresis might be a continuation of daytime polyuria, influenced by the sedative effects of other psychotropic medications.</p><p>Since various types of psychotropic medications, including antipsychotics, antidepressants, anticonvulsants, and benzodiazepines, have been reported to be associated with enuresis under specific conditions, medication-induced enuresis should be considered, particularly when these medications are used in combination. Furthermore, individual differences in response to psychotropics should be taken into account, especially when a rare side effect emerges. Interestingly, there are reports that antidepressants, such as imipramine<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup> and fluvoxamine,<sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup> can be used to treat enuresis. Undoubtedly, these contradictory effects make this condition more complicated. We suspect that these opposing effects may be related to different pathophysiological mechanisms.</p></sec><sec><title>4. Conclusion</title><p>Although lithium carbonate extended-release tablets are relatively safe with strict monitoring of blood lithium concentrations, individual differences in response to lithium may contribute to nocturnal enuresis, particularly when combined with other psychotropics. It is important to be aware of the possibility of lithium-induced nocturnal enuresis when polyuria and polydipsia emerge. Furthermore, the risk of nocturnal enuresis may increase when lithium is combined with other psychotropics.</p></sec><sec><title>Acknowledgments</title><p>The authors would like to thank the patient for her cooperation.</p></sec><sec><title>Author contributions</title><p><bold>Conceptualization:</bold> Bo Liu.</p><p><bold>Project administration:</bold> Youguo Tan.</p><p><bold>Resources:</bold> Yanping Feng, Qingqing Xiang.</p><p><bold>Writing &#x02013; original draft:</bold> Bo Liu.</p><p><bold>Writing &#x02013; review &#x00026; editing:</bold> Yanping Feng, Qingqing Xiang, Xianzhen Dai, Pingping Ma, Youguo Tan.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p>This study was funded by the Projects of Zigong Institute of Brain Science (2023-NKY-01-05 and 2024-NKY-01-04), and the project of research team for psycho-social health services (ZG-KY-2023-050).</p></fn><fn fn-type="other"><p>The study was approved by the Medical Ethics Committee of Zigong Mental Health Center, and the patient&#x02019;s mother provided a written informed consent.</p></fn><fn fn-type="COI-statement"><p>The authors have no conflicts of interest to disclose.</p></fn><fn fn-type="other"><p>Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.</p></fn><fn fn-type="other"><p>How to cite this article: Feng Y, Xiang Q, Dai X, Ma P, Liu B, Tan Y. Nocturnal enuresis associated with lithium carbonate extended-release tablets in a girl with major depressive disorder: A case report. Medicine 2025;104:20(e42505).</p></fn><fn fn-type="other"><p>YF and QX contributed equally to this work.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname><given-names>S</given-names></name><name><surname>Kaneko</surname><given-names>K</given-names></name></person-group>. <article-title>Management of treatment-resistant nocturnal enuresis.</article-title>
<source>Pediatrics Int</source>. <year>2023</year>;<volume>65</volume>:<fpage>e15573</fpage>.</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Movig</surname><given-names>KL</given-names></name><name><surname>Leufkens</surname><given-names>HG</given-names></name><name><surname>Belitser</surname><given-names>SV</given-names></name><name><surname>Lenderink</surname><given-names>AW</given-names></name><name><surname>Egberts</surname><given-names>AC</given-names></name></person-group>. <article-title>Selective serotonin reuptake inhibitor-induced urinary incontinence.</article-title>
<source>Pharmacoepidemiol Drug Saf</source>. <year>2002</year>;<volume>11</volume>:<fpage>271</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">12138594</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horgan</surname><given-names>C</given-names></name><name><surname>Charatcharungkiat</surname><given-names>N</given-names></name></person-group>. <article-title>Fluoxetine-associated enuresis in a pediatric patient.</article-title>
<source>J Clin Psychopharmacol</source>. <year>2024</year>;<volume>44</volume>:<fpage>63</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">38100781</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>TR</given-names></name><name><surname>Drake</surname><given-names>MJ</given-names></name><name><surname>Paton</surname><given-names>C</given-names></name></person-group>. <article-title>Nocturnal enuresis with antipsychotic medication.</article-title>
<source>Br J Psychiatry</source>. <year>2012</year>;<volume>200</volume>:<fpage>7</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">22215862</pub-id>
</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison-Woolrych</surname><given-names>M</given-names></name><name><surname>Skegg</surname><given-names>K</given-names></name><name><surname>Ashton</surname><given-names>J</given-names></name><name><surname>Herbison</surname><given-names>P</given-names></name><name><surname>Skegg</surname><given-names>DC</given-names></name></person-group>. <article-title>Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study.</article-title>
<source>Br J Psychiatry</source>. <year>2011</year>;<volume>199</volume>:<fpage>140</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">21653944</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamak</surname><given-names>WR</given-names></name><name><surname>Hmaimess</surname><given-names>G</given-names></name><name><surname>Makke</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Valproate-induced enuresis: a prospective study.</article-title>
<source>Develop Med Child Neurol</source>. <year>2015</year>;<volume>57</volume>:<fpage>737</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">25808512</pub-id>
</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathyan</surname><given-names>A</given-names></name><name><surname>Scaria</surname><given-names>R</given-names></name><name><surname>Arunachalam</surname><given-names>P</given-names></name><name><surname>Ramasamy</surname><given-names>M</given-names></name><name><surname>Thekkekkara</surname><given-names>D</given-names></name><name><surname>Sivadasan</surname><given-names>S</given-names></name></person-group>. <article-title>Antiepileptic drugs-induced enuresis in children: an overview.</article-title>
<source>J Pharm Technol</source>. <year>2021</year>;<volume>37</volume>:<fpage>114</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">34752569</pub-id>
</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ditman</surname><given-names>KS</given-names></name><name><surname>Gottlieb</surname><given-names>L</given-names></name></person-group>. <article-title>Transient enuresis from chlordiazepoxide and diazepam.</article-title>
<source>Am J Psychiatry</source>. <year>1964</year>;<volume>120</volume>:<fpage>910</fpage>&#x02013;<lpage>1</lpage>.<pub-id pub-id-type="pmid">14129297</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krhut</surname><given-names>J</given-names></name><name><surname>G&#x000e4;rtner</surname><given-names>M</given-names></name></person-group>. <article-title>[Urinary incontinence induced by the antidepressants - case report].</article-title>
<source>Ceska Gynekol</source>. <year>2015</year>;<volume>80</volume>:<fpage>65</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">25723082</pub-id>
</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Bai</surname><given-names>YM</given-names></name><name><surname>Chen</surname><given-names>JY</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Lan</surname><given-names>TH</given-names></name></person-group>. <article-title>A retrospective study of clozapine and urinary incontinence in Chinese in-patients.</article-title>
<source>Acta Psychiatr Scand</source>. <year>1999</year>;<volume>100</volume>:<fpage>158</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">10480202</pub-id>
</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruffalo</surname><given-names>ML</given-names></name></person-group>. <article-title>A brief history of lithium treatment in psychiatry.</article-title>
<source>Primary Care Companion CNS Disord</source>. <year>2017</year>;<volume>19</volume>:<fpage>17br02140</fpage>.</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>CW</given-names></name><name><surname>Carvalho</surname><given-names>AF</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><etal/></person-group>. <article-title>Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: multicenter cohort and meta-analysis.</article-title>
<source>Acta Psychiatr Scand</source>. <year>2021</year>;<volume>144</volume>:<fpage>368</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">34227095</pub-id>
</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudev</surname><given-names>T</given-names></name><name><surname>Mazmanian</surname><given-names>K</given-names></name><name><surname>Weng</surname><given-names>WH</given-names></name><name><surname>Grauffel</surname><given-names>C</given-names></name><name><surname>Lim</surname><given-names>C</given-names></name></person-group>. <article-title>Free and bound therapeutic lithium in brain signaling.</article-title>
<source>Acc Chem Res</source>. <year>2019</year>;<volume>52</volume>:<fpage>2960</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">31556294</pub-id>
</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ouyang</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Y</given-names></name></person-group>. <article-title>Hemodynamics and arrhythmia disorder caused by lithium poisoning: a case report.</article-title>
<source>Zhong nan da xue xue bao Yi xue ban = J Central South Univ Med Sci</source>. <year>2024</year>;<volume>49</volume>:<fpage>153</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baird-Gunning</surname><given-names>J</given-names></name><name><surname>Lea-Henry</surname><given-names>T</given-names></name><name><surname>Hoegberg</surname><given-names>LCG</given-names></name><name><surname>Gosselin</surname><given-names>S</given-names></name><name><surname>Roberts</surname><given-names>DM</given-names></name></person-group>. <article-title>Lithium Poisoning.</article-title>
<source>J Intensive Care Med</source>. <year>2017</year>;<volume>32</volume>:<fpage>249</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">27516079</pub-id>
</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Findling</surname><given-names>RL</given-names></name><name><surname>McNamara</surname><given-names>NK</given-names></name><name><surname>Youngstrom</surname><given-names>EA</given-names></name><etal/></person-group>. <article-title>Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder.</article-title>
<source>J Am Acad Child Adolesc Psychiatry</source>. <year>2005</year>;<volume>44</volume>:<fpage>409</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">15843762</pub-id>
</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>RR</given-names></name><name><surname>Campbell</surname><given-names>M</given-names></name><name><surname>Golden</surname><given-names>RR</given-names></name><name><surname>Small</surname><given-names>AM</given-names></name><name><surname>Pataki</surname><given-names>CS</given-names></name><name><surname>Rosenberg</surname><given-names>CR</given-names></name></person-group>. <article-title>Side effects associated with lithium and placebo administration in aggressive children.</article-title>
<source>Psychopharmacol Bull</source>. <year>1992</year>;<volume>28</volume>:<fpage>319</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">1480737</pub-id>
</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girardi</surname><given-names>P</given-names></name><name><surname>Brugnoli</surname><given-names>R</given-names></name><name><surname>Manfredi</surname><given-names>G</given-names></name><name><surname>Sani</surname><given-names>G</given-names></name></person-group>. <article-title>Lithium in bipolar disorder: optimizing therapy using prolonged-release formulations.</article-title>
<source>Drugs R&#x00026;D</source>. <year>2016</year>;<volume>16</volume>:<fpage>293</fpage>&#x02013;<lpage>302</lpage>.</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>A</given-names></name><name><surname>Campos</surname><given-names>AC</given-names></name><name><surname>Marques Sim&#x000f5;es</surname><given-names>J</given-names></name><name><surname>Jord&#x000e3;o</surname><given-names>A</given-names></name></person-group>. <article-title>Lithium-induced Arginine Vasopressin Resistance (AVP-R): a case of chronic exposure to lithium.</article-title>
<source>Cureus</source>. <year>2023</year>;<volume>15</volume>:<fpage>e41677</fpage>.<pub-id pub-id-type="pmid">37575841</pub-id>
</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>BK</given-names></name><name><surname>Ecelbarger</surname><given-names>CM</given-names></name></person-group>. <article-title>Lithium: a versatile tool for understanding renal physiology.</article-title>
<source>Am J Physiol Renal Physiol</source>. <year>2013</year>;<volume>304</volume>:<fpage>F1139</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">23408166</pub-id>
</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapoport</surname><given-names>J</given-names></name><name><surname>Chaimovitz</surname><given-names>C</given-names></name><name><surname>Alroy</surname><given-names>GG</given-names></name><name><surname>Better</surname><given-names>OS</given-names></name></person-group>. <article-title>Lithium-induced nephrogenic diabetes insipidus: studies of tubular function and pathogenesis.</article-title>
<source>Isr J Med Sci</source>. <year>1979</year>;<volume>15</volume>:<fpage>765</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">41818</pub-id>
</mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gepertz</surname><given-names>S</given-names></name><name><surname>Nev&#x000c9;Us</surname><given-names>T</given-names></name></person-group>. <article-title>Imipramine for therapy resistant enuresis: a retrospective evaluation.</article-title>
<source>J Urol</source>. <year>2004</year>;<volume>171</volume>:<fpage>2607</fpage>&#x02013;<lpage>10</lpage>; <comment>discussion 2609</comment>.<pub-id pub-id-type="pmid">15118430</pub-id>
</mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kano</surname><given-names>K</given-names></name><name><surname>Arisaka</surname><given-names>O</given-names></name></person-group>. <article-title>Fluvoxamine and enuresis.</article-title>
<source>J Am Acad Child Adolesc Psychiatry</source>. <year>2000</year>;<volume>39</volume>:<fpage>1464</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref></ref-list></back></article>